Combined prophylactic β-blocker and behavioural migraine management improves 30-day migraine outcomes compared with either strategy alone, or optimised acute treatment only

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Pages (from-to)77-78
Number of pages2
JournalEvidence-Based Medicine
Volume16
Issue number3
DOIs
StatePublished - Jun 1 2011

ASJC Scopus subject areas

  • Medicine(all)

Cite this